Accrued Issuable Equity |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accrued Issuable Equity |
9. ACCRUED ISSUABLE EQUITY
Accrued issuable equity, which represents the fair value of unissued equity instruments that the Company was obligated to issue, consists of the following:
The common stock balance as of December 31, 2019 is primarily related to the fair value of compensation earned by the Company’s Board members and officers that is to be settled by the future issuance of common stock.
On April 9, 2018, the Company issued warrants to purchase 1,030,115 shares of common stock with an issuance date fair value of $247,360, which was included within additional paid- capital.
During the year ended December 31, 2019, the Company accrued approximately $412,000 related to equity awards that were not issued. During the year ended December 31, 2019, the Company issued various equity instruments in satisfaction of approximately $407,000 of accrued obligations. During the year ended December 31, 2019, the Company recognized a loss on the change in fair value of the accrued equity obligations of approximately $65,000.
See Note 12 – Fair Value Measurement and Note 13 - Stockholders’ Equity for additional details. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||